Scribd
Upload
29 views1 page

Labor Befund

The document is a laboratory report from Labor Dr. Limbach detailing the results of a Valproic Acid test for patient Chivadze Papuna. The test result shows a Valproic Acid level of 40.7 mg/l, which is below the therapeutic range of 50.0 - 100.0 mg/l. It recommends pharmacogenetic examination for further clarification if there are deviations from the target value, with additional information provided on available tests.

Uploaded by

Papuna Chivadze
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
29 views1 page

Labor Befund

The document is a laboratory report from Labor Dr. Limbach detailing the results of a Valproic Acid test for patient Chivadze Papuna. The test result shows a Valproic Acid level of 40.7 mg/l, which is below the therapeutic range of 50.0 - 100.0 mg/l. It recommends pharmacogenetic examination for further clarification if there are deviations from the target value, with additional information provided on available tests.

Uploaded by

Papuna Chivadze
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

111

Medizinisches Versorgungszentrum
Labor Dr. Limbach und Kollegen
Im Breitspiel 15, 69126 Heidelberg
Tel: 06221-3432-0 / Fax: 06221-3432-110
www.Labor-Limbach.de

Med.Center MRTSCHEVELI-Labor
Dr. med. I.Rzchiladse Med.Dir Labor Befund
xx Endbefund: 499174784
AI. Kasbegi Av. 9 Eingang / Ausgang: 06.01.2025 / 06.01.2025
GE-0160 TBILISI, Georgia Arztnummer: 10393
Einsenderkennung: XY179277
Patient: Chivadze Papuna
männlich 09.08.1989

Untersuchung Ergebnis Einheit Ref.Bereich (GOÄ)


EDTA plasma, frozen(01) 2024-12-28 12:47:00
Valproic Acid IM.2.5 40.7 mg/l 50.0 - 100.0
50 - 100
toxic range: > 120 mg/L
CEDIA
In the event of unexpected or repeated deviations of the
active substance concentration from the target value, a
pharmacogenetic examination is recommended for further
clarification.
This allows the detection of genetic influences on
metabolization, which enables individual dose adjustment.
Both the targeted examination of individual genes and the
analysis of a pharmacogenetic panel are offered by our
laboratory. In most cases, these tests are not yet covered
by health insurance and must therefore be billed as IGeL
services or directly to the sender. Further information can
be found in our -Labor aktuell-
(https://www.labor-limbach.de/aktuelles/detail/getarticle/Ne
ws/detail/pharmakogenetik-pgx/).
If you have any questions about pharmacogenetic analyses,
your doctor can contact the -Molecular Endocrinology and
Tumor Diagnostics- department, which carries out these tests
(Dr. med. Jens Köhler; Tel.:06221-658883 or
molendokrinologie@labor-limbach.de).

Seite 1

You might also like